High real-world incidence of hepatic dysfunction from cabozantinib plus nivolumab for Japanese patients with metastatic renal cell carcinoma

Toshihide Horiuchi(Tokyo Women's Medical University Adachi Medical Center), Koichi Nishimura(Tokyo Women's Medical University Adachi Medical Center), Kazutaka Nakamura(Tokyo Women's Medical University Hospital), Daisuke Toki(Tokyo Women's Medical University Adachi Medical Center), Yudai Ishiyama(Jacksonville University), Hirohito Kobayashi(Ebina General Hospital), Nanaka Katsurayama(Tokyo Women's Medical University Adachi Medical Center), Yuki Nemoto(Tokyo Women's Medical University Adachi Medical Center)
Japanese Journal of Clinical Oncology
May 4, 2025
Cited by 1


Related Papers